Symposium Explores Clinical Trial Design and Multidrug Resistance in Blood Cancers
Researchers at the Blood Cancer Discovery Symposium presented data on multidrug resistance and clinical trial design.
Tag: blood cancers
Researchers at the Blood Cancer Discovery Symposium presented data on multidrug resistance and clinical trial design.
Our immune systems are equipped to recognize and destroy cancer cells—if they can find them, that is. And with...
From June 23-26, researchers from around the world will gather in Boston for the Third AACR International Meeting on...
Cancers of the blood can initiate in a variety of cells, including in white blood cells (giving rise to lymphoma and leukemia) or in plasma cells...
Lymphomas are a form of blood cancer that begin in lymphocytes, also known as white blood cells. Over the...
During late spring and early summer, the U.S. Food and Drug Administration (FDA) approved four new molecularly targeted therapeutics—alpelisib...